[1] 李铁军,于世凤,王晓敏.1,25?二羟基维生素D3对小鼠骨髓细胞形成破骨细胞样细胞及其骨吸收效应的影响[J].中国骨质疏松杂,2000,6(3):12?15.

[2] 孙元明.源于脾干细胞的破骨细胞诱导生成及培养[J].中国地方病学杂志,2003,22(2):101?103.

[3] Niikura K.Vacuolar ATPase as a drug discovery target[J]. Drug News Perspect，2006, 19(3):139?144.

[4] 王洪复.骨细胞图谱与骨细胞体外培养技术[M].上海:上海科学技术出版社,2001：55.

[5] Hu Y, Nyman J, Muhonen P, et al. Inhibition of the osteoclast V?ATPase by small interfering RNAs[J]. FEBS Lett，2005,579(22):4937?42.

[6] Blair HC, Athanasou NA. Recent advances in osteoclast biology and pathological bone resorption[J]. Histol Histopathol，2004,19(1):189?99.

[7] Stenbeck G, Horton MA. Endocytic trafficking in actively resorbing osteoclasts[J]. J Cell Sci，2004,29:117(Pt 6):827?36.

[8] Jimi E, Shuto T, Koga T. Macrophage colony?stimulating factor and interleukin?1 alpha maintain the survival of osteoclast?like cells[J]Endocrinology，1995,136(2): 808?811.

[9] Li YP, Chen W, Liang Y, et al. Atp6i?deficient mice exhibit severe osteopetrosis due to loss of osteoclast?mediated extracellular acidification[J]. Nat Genet，1999,23(4): 447?451.

[10]Xu J, Cheng T, Feng HT, et al. Structure and function of V?ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis[J]. Histol Histopathol，2007, 22(4):443?54.

[11]Manolson MF, Yu H, Chen W, et al. The a3 isoform of the 100?kDa V?ATPase subunit is highly but differentially expressed in large(≥10 nuclei) and small(≤5 nuclei) osteoclasts[J]. J Biol Chem，2003,278(49):49271?49278.

精品学习网 医药卫生栏目